openPR Logo
Press release

Companion Diagnostics Market Rapid Growth: Research Findings and Key Players (2024-2031) - Abbott Laboratories, Inc., Biomerieux SA, Siemens Healthcare.

10-17-2024 07:44 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Companion Diagnostics Market

Companion Diagnostics Market

Companion Diagnostics Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report can illuminate pathways for informed decision-making and drive strategic growth in Companion Diagnostics Market.

Will the Companion Diagnostics Market become the sector's next big opportunity? To find out, delve into the analysis and projections for Companion Diagnostics Market. This market research study offers in-depth insights into the opportunities, challenges, and trends currently shaping the machinery landscape, enabling industry participants to make informed decisions in a dynamic environment. Take advantage of the opportunity in the Companion Diagnostics Market! (2031)

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/companion-diagnostics-market

The global companion diagnostics market reached US$ 6.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 15.0 billion by 2030. The global companion diagnostics market is expected to exhibit a CAGR of 12.2% during the forecast period (2024-2031).

Key Growth Drivers in Companion Diagnostics Market:

Companion diagnostics are medical devices or tests used to identify specific biomarkers or genetic mutations in patients, helping determine which therapies or drugs will be most effective for them. These diagnostics play a crucial role in personalized medicine by ensuring that patients receive targeted treatments, improving therapeutic outcomes. They are particularly significant in cancer treatment, where they help match patients with the appropriate targeted therapies. Regulatory bodies like the FDA require companion diagnostics for certain drugs to ensure their efficacy and safety. The increasing use of precision medicine is driving the growth of this market.

DataM Intelligence profiles some of the most reputed organizations present in the Companion Diagnostics market. They are as follows:

F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Biomerieux SA, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Guardant Health and Illumina Inc

Segment Covered in the Companion Diagnostics Market:

By Indications: Oncology (Colorectal Cancer, Leukemia, Breast Cancer, Lung Cancer, Others), Neurology, Others.

By Technology: In-situ Hybridization, Immunohistochemistry, Polymerase Chain Reaction, Next-Generation Sequencing, Others.

By End-User: Pharmaceutical and Biopharmaceutical Companies, Research Laboratories, Others.

Regional Analysis:

The global Companion Diagnostics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

Key Developments

On February 10, 2022, Genetron Holdings Limited, a leading precision oncology company in China, specializing in molecular profiling tests and companion diagnostics, announced a collaboration with HUTCHMED (China) Limited. The partnership aims to jointly develop a companion diagnostic (CDx) test for ORPATHYS (savolitinib), a targeted therapy used in cancer treatment, specifically for the Chinese market. This collaboration highlights the growing importance of precision medicine and companion diagnostics in improving targeted cancer therapies in China.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=companion-diagnostics-market

Regional Analysis:

The global Companion Diagnostics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Companion Diagnostics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Points Covered:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Companion Diagnostics market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Companion Diagnostics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Companion Diagnostics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Companion Diagnostics Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/companion-diagnostics-market

FAQ's

Q.1. What are the primary drivers of the Companion Diagnostics Industry?

Q.2. What are the main factors propelling and impeding the growth of the Companion Diagnostics market?

Q.3. What are the general structure, risks, and opportunities of the market?

Q.4. How do the prices, revenue, and sales of the leading Companion Diagnostics market firms compare?

Q.5. What are the main segments of the market and how is it divided up?

Q.6. Which companies dominate the market, and what percentage of the market do they control?

Q.7. What trends are influencing the Companion Diagnostics market now and in the future?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market Rapid Growth: Research Findings and Key Players (2024-2031) - Abbott Laboratories, Inc., Biomerieux SA, Siemens Healthcare. here

News-ID: 3697273 • Views:

More Releases from DataM Intelligence 4market Research LLP

Cell Line Development Market will grow from $5.76 Billion in 2024 to $13.39 Billion by 2033 at 9.9% CAGR, fueled by biologics and R&D demand.
Cell Line Development Market will grow from $5.76 Billion in 2024 to $13.39 Bill …
The cell line development market is witnessing remarkable growth, driven by the increasing demand for biologics, vaccines, and cell-based research applications. According to DataM Intelligence, the market is projected to expand from USD 5.76 billion in 2024 to USD 13.39 billion by 2033, growing at a CAGR of 9.9% during 2025-2033. Cell line development refers to the process of generating stable cell lines that can produce consistent, reliable results in
Cold Plasma Market to Hit $5.62 Billion by 2033 | Key Drivers in Food Safety, Semiconductors & Healthcare
Cold Plasma Market to Hit $5.62 Billion by 2033 | Key Drivers in Food Safety, Se …
According to DataM Intelligence, the global cold plasma market will grow from USD 2.22 billion in 2024 to USD 5.62 billion by 2033, expanding at a CAGR of 10.9% from 2025 to 2033. This strong growth trajectory underscores the increasing recognition of cold plasma's advantages across sectors such as electronics, healthcare, food processing, and aerospace. The cold plasma market also referred to as the non-thermal plasma market is entering a strong
Diagnostic Device Market hits $79.9 Billion by 2031 at 6.9% CAGR, driven by chronic diseases & rising healthcare demand.
Diagnostic Device Market hits $79.9 Billion by 2031 at 6.9% CAGR, driven by chro …
According to DataM Intelligence, the Diagnostic Device Market reached USD 47 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 79.9 billion by 2031. The market is expected to exhibit a CAGR of 6.9% during the forecast period 2024-2031. This strong growth reflects the rising demand for early and accurate disease detection, supported by technological innovations and expanding healthcare access worldwide. The Diagnostic Device Market
Periodontal therapeutics market doubles to $1.95 Billion by 2033, driven by oral health awareness & advanced therapies.
Periodontal therapeutics market doubles to $1.95 Billion by 2033, driven by oral …
Overview of the Market According to DataM Intelligence, the Periodontal Therapeutics Market reached US$ 1,005.93 million in 2024 and is projected to nearly double, reaching US$ 1,950.35 million by 2033. The market is expected to grow at a healthy CAGR of 7.2% during the forecast period (2025-2033). This strong growth outlook highlights the increasing demand for advanced therapies, preventive care solutions, and innovative drug delivery systems to manage periodontal diseases more

All 5 Releases


More Releases for Companion

Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors. The Artificial Intelligence (AI) In Beauty and Cosmetics Market
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673 This latest report researches the industry structure, sales, revenue,
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test